Marshall H Woodworth is Chief Financial Officer of NeuroBo Pharmaceuticals, Inc.. Currently has a direct ownership of 44,279 shares of NRBO, which is worth approximately $72,174. The most recent transaction as insider was on Jun 04, 2025, when has been sold 14,200 shares (Common Stock) at a price of $0.7 per share, resulting in proceeds of $9,940. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.3K
47.21% 3M change
32.19% 12M change
Total Value Held $72,174

Marshall H Woodworth Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2025
BUY
Open market or private purchase
$9,940 $0.7 p/Share
14,200 Added 24.28%
44,279 Common Stock
Mar 01 2025
SELL
Payment of exercise price or tax liability
$4,988 $1.46 p/Share
3,417 Reduced 10.2%
30,079 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
33,496 Added 50.0%
33,496 Common Stock
MHW

Marshall H Woodworth

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on NRBO

Follow NeuroBo Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRBO shares.

Notify only if

Insider Trading

Get notified when an Neuro Bo Pharmaceuticals, Inc. insider buys or sells NRBO shares.

Notify only if

News

Receive news related to NeuroBo Pharmaceuticals, Inc.

Track Activities on NRBO